Apolloni S - Search Results

1

Novel P2X7 Antagonist Ameliorates the Early Phase of ALS Disease and Decreases Inflammation and Autophagy in SOD1-G93A Mouse Model.

Apolloni S, Fabbrizio P, Amadio S, Napoli G, Freschi M, Sironi F, Pevarello P, Tarroni P, Liberati C, Bendotti C, Volonté C. Apolloni S, et al. Int J Mol Sci. 2021 Sep 30;22(19):10649. doi: 10.3390/ijms221910649. Int J Mol Sci. 2021. PMID: 34638992 Free PMC article.

2

Membrane compartments and purinergic signalling: P2X receptors in neurodegenerative and neuroinflammatory events.

Apolloni S, Montilli C, Finocchi P, Amadio S. Apolloni S, et al. FEBS J. 2009 Jan;276(2):354-64. doi: 10.1111/j.1742-4658.2008.06796.x. Epub 2008 Dec 9. FEBS J. 2009. PMID: 19076216 Free article. Review.

3

The proinflammatory action of microglial P2 receptors is enhanced in SOD1 models for amyotrophic lateral sclerosis.

D'Ambrosi N, Finocchi P, Apolloni S, Cozzolino M, Ferri A, Padovano V, Pietrini G, Carrì MT, Volonté C. D'Ambrosi N, et al. Among authors: apolloni s. J Immunol. 2009 Oct 1;183(7):4648-56. doi: 10.4049/jimmunol.0901212. Epub 2009 Sep 4. J Immunol. 2009. PMID: 19734218

4

UDP exerts cytostatic and cytotoxic actions in human neuroblastoma SH-SY5Y cells over-expressing P2Y6 receptor.

Apolloni S, Finocchi P, D'Agnano I, Alloisio S, Nobile M, D'Ambrosi N, Volonté C. Apolloni S, et al. Neurochem Int. 2010 Apr;56(5):670-8. doi: 10.1016/j.neuint.2010.02.003. Epub 2010 Feb 6. Neurochem Int. 2010. PMID: 20144676

5

Purinergic signalling at the plasma membrane: a multipurpose and multidirectional mode to deal with amyotrophic lateral sclerosis and multiple sclerosis.

Amadio S, Apolloni S, D'Ambrosi N, Volonté C. Amadio S, et al. Among authors: apolloni s. J Neurochem. 2011 Mar;116(5):796-805. doi: 10.1111/j.1471-4159.2010.07025.x. Epub 2011 Jan 7. J Neurochem. 2011. PMID: 21214557 Free article. Review.

6

ALS: focus on purinergic signalling.

Volonté C, Apolloni S, Carrì MT, D'Ambrosi N. Volonté C, et al. Among authors: apolloni s. Pharmacol Ther. 2011 Oct;132(1):111-22. doi: 10.1016/j.pharmthera.2011.06.002. Epub 2011 Jun 16. Pharmacol Ther. 2011. PMID: 21704075

7

P2X7 receptors: channels, pores and more.

Volonté C, Apolloni S, Skaper SD, Burnstock G. Volonté C, et al. Among authors: apolloni s. CNS Neurol Disord Drug Targets. 2012 Sep;11(6):705-21. doi: 10.2174/187152712803581137. CNS Neurol Disord Drug Targets. 2012. PMID: 22963440 Review.

8

The NADPH oxidase pathway is dysregulated by the P2X7 receptor in the SOD1-G93A microglia model of amyotrophic lateral sclerosis.

Apolloni S, Parisi C, Pesaresi MG, Rossi S, Carrì MT, Cozzolino M, Volonté C, D'Ambrosi N. Apolloni S, et al. J Immunol. 2013 May 15;190(10):5187-95. doi: 10.4049/jimmunol.1203262. Epub 2013 Apr 15. J Immunol. 2013. PMID: 23589615 Free article.

9

Ablation of P2X7 receptor exacerbates gliosis and motoneuron death in the SOD1-G93A mouse model of amyotrophic lateral sclerosis.

Apolloni S, Amadio S, Montilli C, Volonté C, D'Ambrosi N. Apolloni S, et al. Hum Mol Genet. 2013 Oct 15;22(20):4102-16. doi: 10.1093/hmg/ddt259. Epub 2013 Jun 4. Hum Mol Genet. 2013. PMID: 23736299

10

Brilliant Blue G: what a little more colour can be.

Apolloni S, Volonté C. Apolloni S, et al. CNS Neurol Disord Drug Targets. 2013 Aug;12(5):550-1. doi: 10.2174/18715273113129990070. CNS Neurol Disord Drug Targets. 2013. PMID: 23746137 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

44 results

Search Page